MENU
RVNC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Revance Therapeutics (RVNC) Earnings Date & Reports

A.I. Advisor
published Earnings

RVNC is expected to report earnings to fall 44.30% to -20 cents per share on March 04

Revance Therapeutics RVNC Stock Earnings Reports
Q4'24
Est.
$-0.21
Q3'24
Missed
by $0.10
Q2'24
Est.
$-0.36
Q1'24
Missed
by $0.03
Q4'23
Beat
by $0.03
The last earnings report on November 07 showed earnings per share of -37 cents, missing the estimate of -27 cents. With 514.00K shares outstanding, the current market capitalization sits at 320.48M.
View a ticker or compare two or three
RVNC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of drugs

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
1222 Demonbreun Street
Phone
+1 615 724-7755
Employees
597
Web
https://www.revance.com